dichlororibofuranosylbenzimidazole has been researched along with Leucocythaemia in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Turinetto, V | 1 |
Porcedda, P | 1 |
Orlando, L | 1 |
De Marchi, M | 1 |
Amoroso, A | 1 |
Giachino, C | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Leucocythaemia
Article | Year |
---|---|
The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.
Topics: Apoptosis; Cell Line, Tumor; Cells, Cultured; Cyclin-Dependent Kinases; Dichlororibofuranosylbenzimi | 2009 |